A detailed history of Old Point Trust & Financial Services N A transactions in Cellectis S.A. stock. As of the latest transaction made, Old Point Trust & Financial Services N A holds 250 shares of CLLS stock, worth $512. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Holding current value
$512
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$2.41 - $3.09 $602 - $772
250 New
250 $0

Others Institutions Holding CLLS

About Cellectis S.A.


  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $93.3M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track This Portfolio

Track Old Point Trust & Financial Services N A Portfolio

Follow Old Point Trust & Financial Services N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Point Trust & Financial Services N A, based on Form 13F filings with the SEC.

News

Stay updated on Old Point Trust & Financial Services N A with notifications on news.